CRF1 RECEPTOR ANTAGONIST FOR THE TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA

Provided are methods related to treating congenital adrenal hyperplasia in a subject in need thereof comprising administering to the subject a compound of Formula (I): [INSERT FORMULA] (I), or a pharmaceutically acceptable salt thereof. L'invention concerne des méthodes associées au traitement...

Full description

Saved in:
Bibliographic Details
Main Authors PARKS, Stacy, CUTLER, JR, NGWENYA-JONES, Ayanda, CHARLIER, Anne, ZHANG, Xiaoping, MEHTON, Gurvinder, SAYERS, Brian, LOEWEN, Gordon RAPHAEL, IYOHA, Kingsley, VICKERY, Anthony D, CHAN, Jean L, ROBERTS, Eiry, TAYLOR, Graeme, DOWNING, Kristie M, GIRI, Nagdeep, STIRN, Scott, FARBER, Robert H, COSTA, Christina MARIE, NAKANISHI, Arline
Format Patent
LanguageEnglish
French
Published 16.12.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Provided are methods related to treating congenital adrenal hyperplasia in a subject in need thereof comprising administering to the subject a compound of Formula (I): [INSERT FORMULA] (I), or a pharmaceutically acceptable salt thereof. L'invention concerne des méthodes associées au traitement de l'hyperplasie surrénale congénitale chez un sujet en ayant besoin, comprenant l'administration au sujet d'un composé de formule (I) : [formule] (I), ou un sel pharmaceutiquement acceptable de celui-ci.
Bibliography:Application Number: WO2021US36668